These data indicate that, while aging caspase-2-deficient mice show some similarities in liver phenotypes and gene/protein expression associated with MASLD, pathogenic hyperpolyploidy–mediated liver disease is distinctly caused by the dysregulated levels of ppaLD proteins and is primarily associated with inflammatory-mediated liver disease. Here, CASP2 is linked to metabolic dysfunction-associated steatotic liver disease.